News

Medicines Access: Unlocking the immense potential in cell and gene therapy

Despite several ground-breaking developments, pharmaceutical and biotech companies are often reluctant or unable to invest in cell and gene therapy. Here, we discuss the key challenges to access and how the potential of these innovative treatments can be unlocked. There are an estimated 300 million people worldwide who suffer from

Medicines Access: Unlocking the immense potential in cell and gene therapy

Exclusive Agreement For The Supply and Distribution Of Bicillin® LA

BAP Pharma Limited is pleased to announce the signing of an exclusive agreement for the supply and distribution of Bicillin® L-A (Penicillin G Benzathine) to expand access to the product in the UK and Europe (previously only available in the US)   Product Details Bicillin® L-A is a ready-to-use Benzathine

Exclusive Agreement For The Supply and Distribution Of Bicillin® LA